Analyst Ratings for Cardiff Oncology (CRDF)
CRDF Rating Summary
CRDF Price Target Summary
- Highest: $12.00 (Noble Capital)
- Lowest: $2.00 (Craig-Hallum)
- Average: $7.25
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$7.25 (+705.6%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 70%
Avg. $ Target:
$7.25 (+705.6%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 70%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/15/2026 | H.C. Wainwright | Raghuram Selvaraju | Upgrade | Buy (Neutral) |
9.00 (N/A) |
1.31 (0.90) |
-31.3% | Details |
| 8/12/2026 | William Blair | Andy T. Hsieh | Downgrade | Market Perform (Outperform) |
N/A (N/A) |
1.03 (0.90) |
-12.62% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
